Finsen, Alexandra Vanessa, Geir Christensen, and Ivar Sjaastad. Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse. J Appl Physiol 98: 680 -689, 2005. First published October 8, 2004; doi:10.1152/japplphysiol.00924.2004Our aim was to establish parameters describing systolic and diastolic function in mice after myocardial infarction (MI) that distinguish MI with pulmonary congestion from MI without congestion. Echocardiography, left ventricular (LV) catheterization, and infarct size measurements were performed on days 3, 5, 7, and 14 after ligation of the left coronary artery in C57BL/6 mice. Sham-operated mice were used as controls (Sham). MI mice with lung weight normalized to tibial length Ͼ125% of the average in the corresponding Sham group were considered to have pulmonary congestion (MIchf). MI mice with a smaller increase were called MI nonfailing (MInf). An infarct Ͼ40% of total LV circumference measured in two-dimensional long axis distinguished MIchf from MInf on both an average and an individual basis. Mean maximum rate of rise of LV pressure, LV fractional shortening, and posterior wall shortening velocity were significantly lower in MIchf compared with Sham at all time points and to MInf at 7 days. The diastolic parameters mitral flow deceleration velocity, LV end-diastolic pressure, and maximum rate of decline in LV pressure (LVdP/dtmin) discriminated the MIchf groups from Sham at all time points. Mitral flow deceleration velocity and LVdP/dtmin separated MIchf from MInf at 7 days. In addition to distinguishing all the groups on an average basis, left atrial diameter distinguished all MIchf animals from Sham and MInf. In conclusion, significantly increased left atrial diameter and infarct size Ͼ40% of total LV circumference may serve as major criteria for heart failure with pulmonary congestion after MI in mice. hemodynamic measurements; left ventricular function; heart failure MYOCARDIAL INFARCTION (MI) remains a major cause of cardiac death, and congestive heart failure (CHF) is another serious outcome of MI. Despite substantial research efforts, the mechanisms of the transition to CHF are far from elucidated. The mouse model of MI is of particular relevance in studies of postinfarction CHF, because the model offers the opportunity to study the mechanisms of CHF in genetically engineered mice. In the mouse postinfarction model, some studies (1, 6, 11, 13, 17) have investigated the development of left ventricular (LV) remodeling, using a combination of in vivo and ex vivo methods. However, none of these studies has established parameters that reliably discriminate between MI mice with and without CHF. Reliable parameters for identification of mice with CHF on an individual basis may also be very useful in other models, such as genetically modified mice showing signs of reduced cardiac function. Although such parameters have been established in humans (10) and larger animals (14), those parameters may not be useful in the mouse because of the small size and high heart rate.
mice with CHF on an individual basis may also be very useful in other models, such as genetically modified mice showing signs of reduced cardiac function. Although such parameters have been established in humans (10) and larger animals (14) , those parameters may not be useful in the mouse because of the small size and high heart rate.
Heart failure can be categorized as systolic and/or diastolic. Systolic heart failure is characterized by reduced LV contractility, dilatation of the left ventricle, and a reduction in ejection fraction (EF). In postinfarction CHF in both mice and humans, cardiac systolic performance is often impaired, but diastolic dysfunction might also be present. Reduced diastolic performance is associated with reduced relaxation and ventricular filling because of reduced LV compliance leading to elevated LV filling pressure. In postinfarction CHF, the observed elevation of LV filling pressure can be explained by both systolic and diastolic dysfunction. This may be reflected in an elevated LV end-diastolic pressure (LVEDP). The increased LV filling pressure results in elevation of the pressure in the left atrium and in the pulmonary circulation, which may result in distension of the left atrium and pulmonary congestion.
There are several ways of assessing LV function with echocardiographic and LV pressure measurements. LV systolic performance is often measured as EF or as myocardial shortening velocity in humans (10) . Although the LV EF reflects myocardial contractility, it has limited value when afterload is abnormal and in valvular disease. LV end-systolic and enddiastolic volumes and dimensions also reflect systolic and contractile performance when afterload is normal. Furthermore, the maximum rate of rise of LV pressure (LVdP/dt max ) is highly sensitive to changes in contractility as seen in CHF, but only at constant LVEDP. LV diastolic performance can be assessed by analysis of LV filling patterns (8, 10) . In particular, prolonged deceleration time of early transmitral filling and reduced E/A ratio are useful parameters, because they reflect abnormal LV relaxation and/or diastolic distensibility (15) . The maximum rate of decline in LV pressure (LVdP/dt min ), however, is strongly influenced by the pressure at the time of aortic valve closure and is not a good measure of the rate of isovolumetric relaxation. Reduced LV diastolic performance and elevated LVEDP may result in increased left atrial pressure, and dilatation of the left atrium often ensues in humans (10) and larger animals (14) . Thus we suggest that left atrial diameter (LAD) might also be a useful parameter in mice.
In the present study, cardiac function and infarct size were assessed by means of echocardiography and invasive LV pressure measurements 3, 5, 7, and 14 days after induction of MI in mice. MI mice with pulmonary congestion were compared with both MI mice without pulmonary congestion and sham-operated mice (Sham).
METHODS

The investigation conforms with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996) and was approved by the Norwegian National Animal Research Committee.
Animal model. MI was induced in 8-wk-old female C57BL/6 mice as previously described (16) . Briefly, after being anesthetized with intravenous tail injections of 0.2 ml propofol (10 mg/ml), the animals were tracheotomized and connected to a rodent ventilator (model 874092, B. Braun, Melsungen, Germany) and given a mixture of 1.8 -2.2% isoflurane and ϳ98% oxygen. A thoracotomy was performed in the third intercostal space on the left side, and the left coronary artery was ligated. Sham-operated animals underwent the same procedure except ligation of the artery. At 3, 5, 7, or 14 days after primary surgery, the animals were again anesthetized and intubated before echocardiography, and LV pressure measurements were carried out, as described below. Then the hearts were removed and blotted dry. The right ventricle and atria were removed. In the infarcted hearts, a cut was made longitudinally through the LV free wall from the base to the apex, and, to enable proper unfolding of the infarcted area, one or two further longitudinal cuts were made in the noninfarcted tissue, if necessary. The unfolded endocardia were photographed with a digital camera (Nikon Coolpix 4500). Total endocardial area and infarcted area were then traced ( Fig. 1) , and infarct size as percentage of total area was calculated by use of ImageJ 1.32j software (Wayne Rasband, National Institute of Mental Health). The LV, infarcted area, right ventricular free wall, and lungs were weighed and normalized to tibial length. A priori we decided that MI mice with lung weight (LW) higher than all Sham animals in the corresponding group should be considered to have pulmonary congestion. No Sham mice had a LW Ͼ125% of the mean in their group. A 125% cutoff was close to 4 standard deviations above the mean in the Sham groups. Therefore, MI mice with a LW normalized to tibial length (LW/TL) Ͼ125% of average in the corresponding Sham group were considered to have pulmonary congestion subsequent to an MI and were called MI chf. MI mice with a LW/TL Ͻ125% compared with Sham were considered not to have a significant pulmonary congestion, and this group was called MI nonfailing (MI nf). The average LW/TL values in the MIchf groups were 36 -102% higher than in Sham at the various time points. Furthermore, the LW/TL was 78% higher in MI chf compared with MInf at 7 days (P Ͻ 0.05), but MInf was not significantly different from Sham.
Echocardiography. In vivo heart function was evaluated by echocardiography using a fully digitized VIVID 7 system (GE Vingmed Ultrasound, Horten, Norway) with an i13L 13-MHz linear array transducer designed for the examination of small rodents. The mice were examined in the supine position with closed chests, and the transducer was gently placed in the left parasternal position, in principle as previously described (14) . The images were transferred to a computer and analyzed with EchoPac PC 3.0x software (General Electric). Three representative cycles were analyzed and averaged. Two-dimensional (2D) images of the LV were obtained both in long and short axes at a frame rate of Ͼ200/s. Short axis recordings were obtained at the level of the papillary muscle. M-mode tracings were recorded at the level of both the papillary muscles and the aortic valves, with 2D guidance. LV wall thickness and cavity dimensions were measured through the largest diameter of the ventricle (14) , both in systole and diastole. LV fractional shortening (LVFS), in percent, was calculated by using the following formula LVFS ϭ ͑LVDd Ϫ LVDs͒/LVDd ϫ 100 where LVDd is LV diameter in diastole, and LVDs is LV diameter in systole.
LV circumference and infarcted area were measured in 2D long axis, by freehand tracing of the outer contour of the LV endocardium from LV outflow tract (LVOT) to the LV-left atrial commissure in diastole. Posterior wall shortening velocity (PWSV) and posterior wall relaxation velocity (PWRV) were measured in M-mode by applying a line parallel to the second endocardial contour. Aortic diameter and LAD were measured both in 2D long axis and M-mode.
Doppler measurements. Doppler recordings were obtained in the left parasternal long axis position. Pulsed Doppler was performed at the level of the LVOT, the right ventricular outflow tract (RVOT), and the mitral valve tips. The Doppler signal from RVOT was almost parallel to the blood flow and therefore measured flow reliably. In LVOT, however, the flow direction deviated ϳ20°from being parallel to the chest wall, and the Doppler beam had an angle of 70°to the chest wall. The deviation between the LVOT flow direction and the ultrasound beam, ϳ50°, was corrected digitally online to avoid underestimation of LVOT flow. Mitral flow velocity was measured at the tips of the mitral valves, with the Doppler beam directed parallel to the flow. Cardiac output (CO) was calculated in LVOT by using the following equation
where VTI is the velocity time integral, HR is heart rate, and diameter is measured in LVOT. LV pressure measurements. Immediately after echocardiography was finished, a 1.4-Fr microtip pressure transducer catheter (SPR-671, Millar Instruments, Houston, TX) was introduced into the left ventricle through the right carotid artery for measurements of LV pressures and calculations of its maximal positive and negative first derivatives. Data recorded from 10 -15 consecutive beats were analyzed.
Statistics. Data are expressed as group means Ϯ SE, unless indicated otherwise. Comparisons between groups were made using two-way ANOVA and Newman-Keuls post hoc test in Statistica 6.0. Overall changes with time were compared with the value at 3 days in the same group. By convention (12), inter-and intrascorer reliability was expressed as the average difference between the scorers Ϯ 2 SD, corresponding to mean and "limits of agreement" in the Bland-Altman analysis (2) . Average absolute difference between the scorers was expressed as means Ϯ SD. Between-scorer difference was tested with a paired t-test. Differences were considered significant for P Ͻ 0.05.
RESULTS
Animal characteristics. Ligation of the left coronary artery induced an infarct size which in the MI chf group included Ͼ30% of the LV area and Ͼ40% of the LV circumference (Table 1 ). Both methods of infarct size estimation revealed significantly larger infarcts in MI chf than in MI nf at 7 days, 120 and 43%, respectively. There was a positive correlation between the two methods of calculating infarct size (r 2 ϭ 0.79) (Fig. 2) . Most animals in the MI chf group showed overt clinical signs of CHF, such as tachypnea, strained respiration, and macroscopically congested lungs. LV weight (LVW) normalized to tibial length (LVW/TL) was significantly increased in MI chf compared with Sham at days 3, 7, and 14, and compared with MI nf at 7 days. Right ventricular weight (RVW) normalized to tibial length (RVW/TL) was similarly increased in MI chf compared with Sham at 7 and 14 days and compared with MI nf at 7 days. In MI chf both LVW/TL and RVW/TL were higher at days 7 and 14 compared with day 3 (P Ͻ 0.05).
HR and LV pressure measurements. HR was not significantly different between MI chf and Sham at any time point (Table 2) ; neither was any significant change with time observed. LVdP/dt max (Fig. 3A) and LV systolic pressure were overall reduced in MI chf compared with Sham (35-53% and 11-23%, respectively). LVdP/dt max was 32% lower in MI chf than in MI nf (P Ͻ 0.05). Furthermore, it was found that LVdP/dt min (Fig. 4A ) was significantly lower (29 -48%) in MI chf compared with Sham at all time points. Mean LVdP/ dt min in the MI nf group was significantly higher (32%) than in MI chf and significantly lower (21%) than in Sham. LVEDP was significantly increased (122-308%) in the MI chf groups com- pared with Sham. However, there was no significant difference in LVEDP between MI nf and the other groups at 7 days.
Echocardiographic measurements. We found a significant increase in LV diameter in diastole in MI chf compared with Sham at all time points (39 -61%) (Fig. 3B ) and also compared with MI nf (29%) at 7 days (Table 3) . Furthermore, LV diameter in the MI chf groups showed a gradual and significant increase with time compared with that at 3 days. Representative 2D and M-mode images of these changes are shown in Fig. 5 . As a sign of systolic dysfunction, LVFS (Fig. 3C ) was significantly decreased in MI chf compared with Sham at all time points (63-75%). LVFS in the MI nf group was significantly lower than Sham (54%), but not different from MI chf . Posterior wall thickening, which is considered to be another systolic parameter, was not significantly different in MI chf and MI nf compared with Sham. As a further sign of decreased systolic function, though, we found a reduction in PWSV in MI chf compared with Sham at all time points (14 -31%, Fig. 3D , P Ͻ 0.05) and compared with MI nf at 7 days (14%, P Ͻ 0.05). PWRV, which is a diastolic parameter, did not show any significant difference between the groups at any time points (Fig. 4B) . LAD, which may reflect increased LV diastolic filling pressure, was significantly increased in MI chf compared with Sham at all time points (43-77%) (Table 3) . Also, there was a significant increase in LAD in MI chf at 7 and 14 days compared with 3 days. The MI nf group had a significantly smaller LAD compared with MI chf (44%), but LAD was 23% larger than Sham (P Ͻ 0.05). There was a good correlation between LAD measured in 2D and M-mode (r 2 ϭ 0.95).
Doppler measurements.
Representative Doppler images are shown in Fig. 6 . LVOT VTI was significantly decreased in MI chf compared with Sham at 5 and 7 days, whereas this was the case for peak LVOT flow only at 5 days (Table 4) . CO in LVOT was overall significantly reduced in MI chf compared with Sham and at 5 days (47%). Peak RVOT flow was only significantly reduced in MI chf compared with Sham at 5 days, whereas RVOT VTI showed no significant differences.
Mitral flow deceleration velocity (Mit dec) (Fig. 4C ) was significantly increased in MI chf compared with Sham at all time points (37-44%) and compared with MI nf at 7 days (39%). Peak mitral flow velocity showed an overall reduction in MI chf compared with Sham but was only significantly different at 7 days.
Inter-and intrascorer reliability. To assess interscorer reliability, echocardiographic measurements were analyzed by two persons who were blinded for the intervention carried out. Also, one scorer analyzed the measurements twice, on separate days, to evaluate intrascorer reliability. LAD in 2D and M-mode, LVFS, PWSV, and Mit dec were evaluated in a subset of 10 mice. These parameters were chosen because they were considered the most central in describing either increased LV filling pressure, systolic function, or diastolic function. Both intra-and interscorer reliabilities were found acceptable with a mean difference Ͻ10% (Table 5) . No statistically significant differences were found. Both the intra-and interscorer differences for LAD were as low as 0.00 Ϯ 0.01 and 0.00 Ϯ 0.02 mm, respectively, in both 2D and M-mode. Parameters distinguishing MI chf from MI nf and Sham at 7 days. As seen in Fig. 7A , all MI chf animals had an infarct area Ͼ30% of total LV endocardial area, whereas that was the case for none in the MI nf group. The average values for LV systolic pressure and LVEDP only separated the MI chf group from the Sham group, whereas LVdP/dt max and LVdP/dt min distinguished MI chf from both MI nf and Sham (Table 2) . However, the individual values for all of these parameters showed overlap between the groups (LVEDP illustrated in Fig. 7B ). The noninvasive systolic parameter LVFS distinguished MI chf and MI nf from Sham on an average basis, but MI chf and MI nf were not significantly different. On an individual basis there was near-complete overlap between the values for LVFS in the MI chf and MI nf groups and no overlap between MI chf and Sham, whereas one measurement in the MI nf group overlapped with Sham (Fig. 7C) . PWSV showed a significant difference between MI chf and both MI nf and Sham. There was no overlap between the individual values for PWSV in the MI chf and Sham groups, but 5 of 10 measurements in the MI nf group overlapped with MI chf and 5 of 10 in the MI nf group overlapped with Sham. Another systolic parameter, LVDd, separated all of the groups with regard to average values and in addition distinguished every animal in the MI chf group from Sham. However, 1 out of 9 measurements in the MI chf group overlapped with MI nf (Fig. 7D) . The diastolic parameter Mit dec separated MI chf from both MI nf and Sham on an average basis, whereas 1 of 7 measurements in the Sham group and 2 of 10 in the MI nf group overlapped with MI chf (Fig. 7E) . A fifth noninvasive parameter, LAD, distinguished MI chf from both MI nf and Sham on an average basis and in addition showed no overlap for individual values (Fig. 7F) . LAD in MI nf was also significantly increased compared with Sham, but had considerable overlap.
DISCUSSION
Echocardiography is a noninvasive method that can give serial and detailed information on in vivo cardiac function in mice. In this study we used a state-of-the-art, fully digital echocardiographic system with modified software to give sufficient time resolution to allow reliable 2D, M-mode, and Doppler measurements in mice. Echocardiographic measurements were compared with LV pressure recordings and infarct size calculations. On an individual basis, only infarct size and LAD were found to separate MI chf from MI nf .
Systolic function. We found that LV systolic function was markedly impaired in mice with MI chf . This was evidenced by a depression in LVFS compared with Sham already at 3 days. At 7 days we did not find a significant difference in LVFS between MI chf and MI nf . PWSV measures the shortening velocity of viable myocardium in the posterior wall rather than the alterations in LV cavity dimensions measured by LVFS. In our study, mean PWSV in the MI chf groups were significantly lower than in Sham at all time points and also compared with MI nf at 7 days. These results are in line with a previous study in postinfarction CHF rats (14) .
Subsequent to MI, dilatation of the noninfarcted parts of the LV may follow, which is often accompanied by a shift of the pressure-volume curve to the right. LVDd is therefore related to LV systolic function, and both murine (11) and human (3, 5) studies have shown an increased LVDd in postinfarction CHF. LV dilatation is thought to reflect the increase in LV volume occurring as a compensatory mechanism to restore stroke volume at the early stages. Later it may, however, reflect decompensatory dilatation with hemodynamic deterioration. Gehrmann et al. (7) found that mice subjected to MI had increased apical LV diameters compared with Sham, as early as 24 h postinfarction, but did not investigate at later time points. Gao et al. (6) , on the other hand, did not find any change in LVDd after 1 wk, but found an increase after 2.5 wk. Yang et al. (17) found that LVDd had increased after 1 wk and Values are means Ϯ SE; n, no. of animals. Mit V max peak mitral flow; Mit dec, mitral deceleration velocity; LVOT V max, peak left ventricular outflow tract flow; VTI, velocity time integral; CO, cardiac output; RVOT V max, peak right ventricular outflow tract flow. *MIchf significantly different from Sham (P Ͻ 0.05); †MIchf significantly different from MInf (P Ͻ 0.05); §significantly different from same group at 3 days (P Ͻ 0.05). remained stable from 2 wk. The last study is in line with the present study, in which we found an increased LVDd in the MI chf groups compared with Sham as early as at 3 days, as well as a gradual increase until 14 days. Taken together, these studies suggest that LV diameter is increased early after the infarction, gradually dilates during the first 2 wk, and thereafter possibly remains stable.
Catheterization of the LV showed that LVdP/dt max was reduced in MI chf compared with Sham at every time point measured, and LVdP/dt max recorded in the MI chf group at 7 days showed a significant difference from both MI nf and Sham. This fits with the reduction in PWSV found in MI chf . In agreement with our findings, Gao et al. (6) and Pons et al. (11) both found a reduction in LVdP/dt max subsequent to MI, but in those studies they did not distinguish between MI chf and MI nf .
Diastolic function. Measuring LV filling patterns by echocardiography is often the preferred method for evaluating LV diastolic function (8, 10, 15) . However, estimating the E/A ratio proved difficult in our study, because of fusion of the two waves in the mitral inflow signal in most of the mice. The separation of the E and A waves is heart rate dependent, and in the present study the waves fused at frequencies above ϳ400. On the other hand, our results showed a significant increase in average Mit dec in MI chf compared with Sham at all time points and also a large difference between MI chf and MI nf at 7 days. This indicates impaired diastolic function in MI chf , but not in MI nf . This parameter has not previously been examined in mice, but from human studies we know that an increase in early deceleration time is associated with reduced LV compliance (10, 15) . Another echocardiographic parameter that assesses diastolic function, PWRV, was found to be not different in MI chf compared with MI nf and Sham. Thus this parameter might be less sensitive to diastolic dysfunction than Mit dec. Another method used to evaluate relaxation velocities is tissue Doppler. However, this method has not been established in mice, probably because of insufficient time resolution. The invasive diastolic parameter, LVdP/dt min , was significantly decreased in MI chf compared with MI nf , as well as significantly different in the MI chf and Sham groups. This supports the presence of diastolic dysfunction in MI chf .
LVEDP and LAD. The present investigation showed an increase in mean LVEDP in the MI chf groups compared with Sham, but no difference compared with MI nf at 7 days. Also, others (9) have found significantly elevated LVEDP in mice with postinfarction heart failure compared with controls but have not distinguished MI chf from MI nf . However, LV pressure measurements require cannulation of the right carotid artery, which prevents longitudinal studies. In addition, and especially in mice because of the relatively large catheter dimensions, catheterization may cause damage to the aortic valves and significantly affect cardiac performance. Furthermore, we found no indication that any of the invasive measures could discriminate between the groups any better than the noninvasive echocardiographic parameters, with regard to systolic and diastolic function.
LAD has not been measured in previous studies on mice. However, in humans the finding of an enlarged left atrium is consistent with a diagnosis of diastolic dysfunction (15) . As shown in Table 3 , mean LAD distinguished the MI chf group from both MI nf and Sham and showed a significant increase with time at 7 and 14 days compared with 3 days. This may reflect gradually increasing left atrial pressure, or just a gradual distention of the atrium in response to an elevated but unchanged atrial pressure. When measured in 2D, LAD was larger in MI nf than in Sham, despite no change in LW (Fig.  7F ). This could be due to elevated atrial pressure in MI nf subsequent to a slightly increased (37%) LV filling pressure compared with Sham. However, this rise in LV filling pressure may be insufficient to cause pulmonary congestion.
Echocardiographic method. Echocardiographic descriptions of the murine postinfarction model have been carried out by others recently (1, 6, 11, 17, 18) , but the equipment used has often had technical limitations. The depth of interest in the mouse is 0 -10 mm, which is too short a distance for ordinary cardiac transducers to be able to focus on the relevant area. To achieve a suitable focus area, high-frequency vessel transducers have been used in previous studies. However, the frame rate was often too slow to truly sample systolic and diastolic frames in 2D. The fully digitized echocardiography system used in the present study had its software modified to allow recordings in 2D at Ͼ200 frames per second, which allows sampling of true end-systolic and end-diastolic frames. Also, the use of a 13-MHz transducer especially designed for studies in small rodents allowed for high-resolution imaging combined with a short focus distance (0 mm). These improvements resulted in high-quality recordings in 2D. Furthermore, we were able to analyze our data offline with the opportunity to adjust gain and time scale for optimal resolution. Adjustment of gain and time scale during post hoc analysis may reduce reproducibility compared with conventional analysis of printouts. However, we have shown that our reproducibility is within acceptable limits (Table 5) .
Parameters discriminating MI chf , MI nf , and Sham. Most investigators agree that there is a gradual transition from asymptomatic compensated heart failure to decompensated symptomatic failure, but it is often difficult to assess the degree of failure in mice with MI. Previous studies on postinfarction mice have not discriminated between failing and nonfailing animals. In the present study, we evaluated an extensive list of parameters that could potentially be used as criteria for postinfarction MI chf . An increase in RVW normalized to body weight has previously been used as an indicator of CHF in the rat (4). Our results showing a significant increase in RVW/TL only at the two later time points could indicate that this parameter discriminates between early and later stages of CHF. However, Values are means Ϯ 2 SD of the individual differences between scores made by 2 scores and between the 2 scores made by 1 scorer on different days, corresponding to means and the "limit of agreement" in the Bland-Altman analysis. The absolute (Abs) difference is used to avoid positive and negative differences canceling each other, and the data are presented as % Ϯ SD. Mean difference represents accuracy of reading data, whereas mean absolute difference represents dispersal of reading data. MM, M-mode.
there was overlap between individual values in the different groups at these time points. Furthermore, RVW will only increase in cases with substantially elevated pressure in the pulmonary circulation. In cases with only modest pulmonary congestion, the pressure in arteria pulmonalis does not increase enough to result in an increase in RVW (3). Thus increased RVW is not a prerequisite for a diagnosis of pulmonary congestion. All MI chf animals had an infarct area Ͼ30% of the LV area, whereas none in the MI nf group had infarcts that were that large (Fig. 7A) . Although measuring infarct area discriminates well on an individual basis, it is, however, terminally invasive. On the other hand, we found that estimating infarct size as percentage of total LV circumference measured noninvasively by 2D echocardiography also discriminated every MI chf animal from the MI nf group. All MI chf animals were found to have an infarct Ͼ40% of the LV circumference. Although moderately overestimated compared with planimetric measurements of infarct area, the data obtained by the two different methods showed a reasonably good correlation, and therefore one could argue that this might be a very useful parameter for classifying the mice.
Mean LVFS separated both MI chf and MI nf from Sham, and there was only one individual result in the MI nf group that overlapped with Sham. However, there was an almost complete overlap between individual results in the MI chf and MI nf groups, making this parameter unsuited for categorizing the mice. We found that, although LVDd distinguished MI chf , MI nf , and Sham well on an average basis, individual values from all three groups overlapped to a certain degree. Sjaastad et al. (14) found that PWSV managed to separate all MI chf from MI nf in the rat, but in our investigation there was an overlap between individual measurements in the MI chf and MI nf groups. This indicates that PWSV may not be used as a criterion for postinfarction MI chf in mice, even though it can in rats. Of the diastolic parameters, mean Mit dec in MI chf was significantly different from both MI nf and Sham and was the parameter best able to separate MI chf from the other groups. However, Mit dec did not separate individual animals in the MI chf group from MI nf and Sham. LVdP/dt min was decreased in MI chf compared with Sham at all time points, and MI nf was different from MI chf and Sham. There was, however, overlap between LVdP/dt min values in all three groups at 7 days. In larger animals, such as rats, LAD has been shown to discriminate between animals with and without heart failure (14) . In agreement with this, we found that LAD could on an individual basis completely distinguish MI chf from MI nf and Sham. Furthermore, we found this parameter to have a high degree of reliability, judged by a small inter-and intraobserver variability and a high correlation between measurements obtained in 2D and M-mode. For these reasons, we suggest that it is feasible to use this noninvasive measure as a main criterion for postinfarction CHF.
Limitations of the study. This investigation was carried out under specific experimental conditions, including a degree of sedation, certain age of the mice, and certain time from induction of infarction.
In conclusion, our study showed that the systolic parameters LVdP/dt max , LVFS, and PWSV were decreased in MI chf compared with Sham at all time points investigated. We also found that the diastolic parameters Mit dec and LVdP/dt min differed significantly in MI chf compared with Sham at all time points. Only LAD and infarct size could distinguish all MI chf animals from both Sham and MI nf . We therefore suggest that a significantly increased LAD and infarct size Ͼ40% of total LV circumference may serve as major criteria for postinfarction CHF in the mouse.
